SPI-II Score | Patients (%) | Strokes (%) | Percent risk (95% CI) |
---|---|---|---|
0 | |||
1 | 2 (0.4%) | 2 (1.1%) | 100 (15.8–100.0) |
2 | 64 (11.8%) | 16 (8.8%) | 25.0 (15.0–37.4) |
3 | 102 (18.8%) | 29 (16.0%) | 28.4 (19.9–38.2) |
4 | 28 (5.2%) | 6.0 (3.3%) | 21.4 (8.8–40.9) |
5 | 92 (16.9%) | 21 (11.6%) | 22.8 (14.7–32.7) |
6 | 107 (19.7%) | 34 (18.8%) | 31.8 (23.1–41.5) |
7 | 10 (1.8%) | 4 (2.2%) | 40 (12.6–73.8) |
8 | 88 (16.2%) | 32 (17.7%) | 36.4 (26.4–47.3) |
9 | 32 (5.9) | 21 (11.6) | 65.6 (46.8–81.4) |
10 | 2 (0.4) | 2 (1.1) | 100 (15.8–100.0) |
11 | 9 (1.7) | 8 (4.4) | 88.9 (51.7–99.72) |
12 | 7 (1.3) | 6 (3.3) | 85.7 (42.1–99.6) |
13 | 0 | 0 | 0 |
14 | 0 | 0 | 0 |
15 | 0 | 0 | 0 |
Total | 543 (100%) | 181 (100%) | |
ESRS score | Patients (%) | Stroke (%) | Percent risk (95% CI) |
0 | 35 (6.4%) | 6 (3.3%) | 17.1 (6.6–33.7) |
1 | 86 (15.8%) | 25 (13.8%) | 29.1 (19.8–39.9) |
2 | 135 (24.9%) | 31 (17.1%) | 22.9 (16.2–30.9) |
3 | 151 (27.8%) | 52 (28.7%) | 34.4 (26.9–42.6) |
4 | 91 (16.8%) | 43 (23.8%) | 47.3 (36.7–58.0) |
5 | 35 (6.4%) | 17 (9.4%) | 48.6 (31.4–66.0) |
6 | 9 (1.7%) | 6 (3.3%) | 66.7 (29.9–92.5) |
7 | 1 (0.2%) | 1 (0.6%) | 100 (2.5–100.0) |
8 | 0 | 0 | 0 |
9 | 0 | 0 | 0 |
Total | 543 (100%) | 181 (100%) |